• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后的心血管疾病

Cardiovascular disease after renal transplantation.

作者信息

Kasiske B L, Guijarro C, Massy Z A, Wiederkehr M R, Ma J Z

机构信息

Department of Medicine, University of Minnesota College of Medicine, Minneapolis 55415, USA.

出版信息

J Am Soc Nephrol. 1996 Jan;7(1):158-65. doi: 10.1681/ASN.V71158.

DOI:10.1681/ASN.V71158
PMID:8808124
Abstract

Although cardiovascular disease is a major cause of morbidity and mortality after renal transplantation, its pathogenesis and treatment are poorly understood. We conducted separate analyses of risk factors for ischemic heart disease, cerebral, and peripheral vascular disease after 706 renal transplants, all of which functioned for at least 6 months. We used Cox proportional hazards analysis to examine the effects of multiple pretransplant and posttransplant risk factors and included time-dependent variables measured at 3, 6, and 12 months, and annually to last follow-up at 7.0 +/- 4.2 yr. The independent relative risk (RR) of diabetes was 3.25 for ischemic heart disease, 3.21 for cerebral vascular disease, and 28.18 peripheral vascular disease (P < 0.05). The RR of each acute rejection episode was 1.40 for ischemic heart disease and 1.24 for cerebral vascular disease. Among serum lipid levels, high-density lipoprotein cholesterol was the best predictor of ischemic heart disease (RR = 0.80 for each 10 mg/dL). Posttransplant ischemic heart disease was strongly predictive of cerebral (5.80) and peripheral vascular disease (5.22), whereas ischemic heart disease was predicted by posttransplant cerebral (8.25) and peripheral vascular disease (4.58). Other risk factors for vascular disease included age, gender, cigarette smoking, pretransplant splenectomy, and serum albumin. Hypertension and low-density lipoprotein cholesterol had no effect, perhaps because of aggressive pharmacologic treatment. Thus, the incidence of cardiovascular disease continues to be high after renal transplantation, and multiple risk factors suggest a number of possible strategies for more effective treatment and prevention.

摘要

尽管心血管疾病是肾移植后发病和死亡的主要原因,但其发病机制和治疗方法仍知之甚少。我们对706例肾移植术后的缺血性心脏病、脑血管疾病和外周血管疾病的危险因素进行了单独分析,所有移植肾均至少发挥功能6个月。我们使用Cox比例风险分析来检验多个移植前和移植后危险因素的影响,并纳入了在3、6和12个月以及每年直至7.0±4.2年最后随访时测量的时间依赖性变量。糖尿病的独立相对风险(RR)在缺血性心脏病中为3.25,在脑血管疾病中为3.21,在外周血管疾病中为28.18(P<0.05)。每次急性排斥反应的RR在缺血性心脏病中为1.40,在脑血管疾病中为1.24。在血脂水平中,高密度脂蛋白胆固醇是缺血性心脏病的最佳预测指标(每10mg/dL的RR = 0.80)。移植后缺血性心脏病强烈预测脑血管疾病(5.80)和外周血管疾病(5.22),而缺血性心脏病则由移植后脑血管疾病(8.25)和外周血管疾病(4.58)预测。血管疾病的其他危险因素包括年龄、性别、吸烟、移植前脾切除术和血清白蛋白。高血压和低密度脂蛋白胆固醇没有影响,可能是因为积极的药物治疗。因此,肾移植后心血管疾病的发病率仍然很高,多种危险因素提示了一些更有效的治疗和预防策略。

相似文献

1
Cardiovascular disease after renal transplantation.肾移植后的心血管疾病
J Am Soc Nephrol. 1996 Jan;7(1):158-65. doi: 10.1681/ASN.V71158.
2
[Incidence of cardiovascular risk factors and complications after kidney transplantation].[肾移植后心血管危险因素及并发症的发生率]
Med Klin (Munich). 1999 Sep 15;94(9):478-84. doi: 10.1007/BF03044939.
3
Cardiovascular risk factors and diseases after renal transplantation.
Int Urol Nephrol. 1998;30(6):777-88. doi: 10.1007/BF02564867.
4
Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study.肾移植后 1 年发生代谢性酸中毒与随后的心血管事件和死亡:一项观察性队列研究。
Am J Kidney Dis. 2019 Apr;73(4):476-485. doi: 10.1053/j.ajkd.2018.12.023. Epub 2019 Jan 28.
5
Incidence of cardiovascular risk factors and complications before and after kidney transplantation.肾移植前后心血管危险因素及并发症的发生率。
Transplant Proc. 2006 Mar;38(2):506-8. doi: 10.1016/j.transproceed.2006.01.001.
6
Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up.挪威稳定期肾移植患者的心血管疾病:5年随访期间的发病率和死亡率
Clin Transplant. 2004 Oct;18(5):596-604. doi: 10.1111/j.1399-0012.2004.00235.x.
7
Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study.预测肾移植后的冠心病:肾移植患者结局研究(PORT 研究)。
Am J Transplant. 2010 Feb;10(2):338-53. doi: 10.1111/j.1600-6143.2009.02949.x.
8
Posttransplant proteinuria is associated with higher risk of cardiovascular disease and graft failure in renal transplant patients.肾移植患者移植后蛋白尿与心血管疾病和移植肾失功的较高风险相关。
Transplant Proc. 2009 Jun;41(5):1604-8. doi: 10.1016/j.transproceed.2008.12.034.
9
Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.心血管危险因素对同种异体移植和肾移植患者生存的患病率演变及影响。
Transplant Proc. 2009 Jul-Aug;41(6):2151-5. doi: 10.1016/j.transproceed.2009.06.134.
10
Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.心血管风险与肾移植:肾移植中氟伐他汀评估(ALERT)研究的事后分析
Am J Kidney Dis. 2005 Sep;46(3):529-36. doi: 10.1053/j.ajkd.2005.05.014.

引用本文的文献

1
Risks of cardiovascular disease and cerebrovascular disease following kidney transplantation: A nationwide, population-based cohort study.肾移植后心血管疾病和脑血管疾病的风险:一项基于全国人群的队列研究。
Int J Med Sci. 2025 Apr 13;22(9):2237-2246. doi: 10.7150/ijms.108744. eCollection 2025.
2
From Risk Assessment to Management: Cardiovascular Complications in Pre- and Post-Kidney Transplant Recipients: A Narrative Review.从风险评估到管理:肾移植受者术前及术后的心血管并发症:一篇叙述性综述
Diagnostics (Basel). 2025 Mar 21;15(7):802. doi: 10.3390/diagnostics15070802.
3
A structured, home-based exercise programme in kidney transplant recipients (ECSERT): A randomised controlled feasibility study.
肾移植受者的结构化家庭锻炼计划(ECSERT):一项随机对照可行性研究。
PLoS One. 2025 Feb 24;20(2):e0316031. doi: 10.1371/journal.pone.0316031. eCollection 2025.
4
Impact of Arterial Calcification on Cardiovascular and Renal Outcomes in Kidney Transplant Patients.动脉钙化对肾移植患者心血管和肾脏结局的影响。
Kidney Dis (Basel). 2024 Apr 16;10(4):249-261. doi: 10.1159/000538929. eCollection 2024 Aug.
5
Post-Transplant Cardiovascular Disease in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes in the Era of Modern Immunosuppression.肾移植受者的移植后心血管疾病:现代免疫抑制时代的发病率、危险因素及结局
J Clin Med. 2024 May 7;13(10):2734. doi: 10.3390/jcm13102734.
6
Impact of Immunosenescence in Older Kidney Transplant Recipients: Associated Clinical Outcomes and Possible Risk Stratification for Immunosuppression Reduction.老年肾移植受者免疫衰老的影响:相关临床结局及免疫抑制减少的可能风险分层。
Drugs Aging. 2024 Mar;41(3):219-238. doi: 10.1007/s40266-024-01100-5. Epub 2024 Feb 22.
7
[Comprehensive care for kidney transplantation-optimization of interdisciplinary support before and after kidney transplantation].[肾移植综合护理——肾移植前后跨学科支持的优化]
Urologie. 2024 Apr;63(4):333-340. doi: 10.1007/s00120-024-02290-x. Epub 2024 Feb 21.
8
Association of Genotypes of ANGPTL3 with Vitamin D and Calcium Concentration in Cardiovascular Disease.ANGPTL3 基因型与心血管疾病中维生素 D 和钙浓度的关系。
Biochem Genet. 2024 Aug;62(4):2482-2494. doi: 10.1007/s10528-023-10533-3. Epub 2023 Nov 13.
9
Population Characteristics and Clinical Outcomes from the Renal Transplant Outcome Prediction Validation Study (TOPVAS).肾移植结局预测验证研究(TOPVAS)的人群特征与临床结果
J Clin Med. 2022 Dec 14;11(24):7421. doi: 10.3390/jcm11247421.
10
Clinical outcomes of posttransplantation diabetes mellitus in kidney transplantation recipients: a nationwide population-based cohort study in Korea.肾移植受者移植后糖尿病的临床结局:韩国一项全国基于人群的队列研究。
Sci Rep. 2022 Dec 14;12(1):21632. doi: 10.1038/s41598-022-25070-z.